Literature DB >> 18222045

Modular and laminar pathology of Brodmann's area 37 in Alzheimer's disease.

R Thangavel1, S K Sahu, G W Van Hoesen, A Zaheer.   

Abstract

Previous studies suggested a relationship between severity of symptoms and the degree of neurofibrillary tangles (NFTs) clustering in different areas of the cortex in Alzheimer's disease (AD). The posterior inferior temporal cortex or Brodmann's area (BA 37) is involved in object naming and recognition memory. But the cellular architecture and connectivity and the NFT pathology of this cortex in AD received inadequate attention. In this report, we describe the laminar distribution and topography of NFT pathology of BA 37 in brains of AD patients by using Thionin staining for Nissl substance, Thioflavin-S staining for NFTs, and phosphorylated tau (AT8) immunohistochemistry. NFTs mostly occurred in cortical layers II, III, V and VI in the area 37 of AD brain. Moreover, NFTs appeared like a patch or in cluster pattern along the cortical layers III and V and within the columns of pyramidal cell layers. The abnormal, intensely labeled AT8 immunoreactive cells were clustered mainly in layers III and V. Based on previously published clinical correlations between cognitive abnormalities in AD and the patterns of laminar distributed NFT cluster pathology in other areas of the brain, we conclude that a similar NFT pathology that severely affected BA 37, may indicate disruption of some forms of naming and object recognition-related circuits in human AD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222045      PMCID: PMC2350243          DOI: 10.1016/j.neuroscience.2007.12.025

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

Authors:  J L Price; J C Morris
Journal:  Ann Neurol       Date:  1999-03       Impact factor: 10.422

2.  Columns for visual features of objects in monkey inferotemporal cortex.

Authors:  I Fujita; K Tanaka; M Ito; K Cheng
Journal:  Nature       Date:  1992-11-26       Impact factor: 49.962

Review 3.  Entorhinal cortex pathology in Alzheimer's disease.

Authors:  G W Van Hoesen; B T Hyman; A R Damasio
Journal:  Hippocampus       Date:  1991-01       Impact factor: 3.899

4.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease.

Authors:  J L Price; P B Davis; J C Morris; D L White
Journal:  Neurobiol Aging       Date:  1991 Jul-Aug       Impact factor: 4.673

5.  Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease: II. Primary and secondary visual cortex.

Authors:  P R Hof; J H Morrison
Journal:  J Comp Neurol       Date:  1990-11-01       Impact factor: 3.215

6.  Evidence for early vulnerability of the medial and inferior aspects of the temporal lobe in an 82-year-old patient with preclinical signs of dementia. Regional and laminar distribution of neurofibrillary tangles and senile plaques.

Authors:  P R Hof; L M Bierer; D P Perl; A Delacourte; L Buée; C Bouras; J H Morrison
Journal:  Arch Neurol       Date:  1992-09

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Phosphorylation of tau by fyn: implications for Alzheimer's disease.

Authors:  Gloria Lee; Ramasamy Thangavel; Vandana M Sharma; Joel M Litersky; Kiran Bhaskar; Sandy M Fang; Lana H Do; Athena Andreadis; Gary Van Hoesen; Hanna Ksiezak-Reding
Journal:  J Neurosci       Date:  2004-03-03       Impact factor: 6.167

9.  On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

10.  The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease.

Authors:  S E Arnold; B T Hyman; J Flory; A R Damasio; G W Van Hoesen
Journal:  Cereb Cortex       Date:  1991 Jan-Feb       Impact factor: 5.357

View more
  17 in total

1.  Augmented expression of glia maturation factor in Alzheimer's disease.

Authors:  S Zaheer; R Thangavel; S K Sahu; A Zaheer
Journal:  Neuroscience       Date:  2011-08-02       Impact factor: 3.590

2.  Efficient down-regulation of glia maturation factor expression in mouse brain and spinal cord.

Authors:  Smita Zaheer; Yanghong Wu; Xi Yang; Ramasamy Thangavel; Shailendra K Sahu; Asgar Zaheer
Journal:  Neurochem Res       Date:  2012-03-25       Impact factor: 3.996

3.  Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.

Authors:  Ramasamy Thangavel; Sachin M Bhagavan; Swathi Beladakere Ramaswamy; Spurthi Surpur; Raghav Govindarajan; Duraisamy Kempuraj; Smita Zaheer; Sudhanshu Raikwar; Mohammad E Ahmed; Govindhasamy Pushpavathi Selvakumar; Shankar S Iyer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  Gene x disease interaction on orbitofrontal gray matter in cocaine addiction.

Authors:  Nelly Alia-Klein; Muhammad A Parvaz; Patricia A Woicik; Anna B Konova; Thomas Maloney; Elena Shumay; Ruiliang Wang; Frank Telang; Anat Biegon; Gene-Jack Wang; Joanna S Fowler; Dardo Tomasi; Nora D Volkow; Rita Z Goldstein
Journal:  Arch Gen Psychiatry       Date:  2011-03

5.  Clinical course of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis is aggravated by glia maturation factor.

Authors:  Smita Zaheer; Yanghong Wu; Xi Yang; Marcus Ahrens; Shailendra K Sahu; Asgar Zaheer
Journal:  Neurochem Int       Date:  2011-12-30       Impact factor: 3.921

6.  Analysis of Alzheimer's disease severity across brain regions by topological analysis of gene co-expression networks.

Authors:  Monika Ray; Weixiong Zhang
Journal:  BMC Syst Biol       Date:  2010-10-06

7.  Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain.

Authors:  Ramasamy Thangavel; Duraisamy Kempuraj; Deirdre Stolmeier; Poojya Anantharam; Mohammad Khan; Asgar Zaheer
Journal:  Neurochem Res       Date:  2013-05-29       Impact factor: 3.996

8.  Posterior parahippocampal gyrus pathology in Alzheimer's disease.

Authors:  R Thangavel; G W Van Hoesen; A Zaheer
Journal:  Neuroscience       Date:  2008-04-08       Impact factor: 3.590

9.  The abnormally phosphorylated tau lesion of early Alzheimer's disease.

Authors:  Ramasamy Thangavel; Gary W Van Hoesen; Asgar Zaheer
Journal:  Neurochem Res       Date:  2008-04-25       Impact factor: 3.996

10.  Glia maturation factor expression in hippocampus of human Alzheimer's disease.

Authors:  Deirdre Stolmeier; Ramasamy Thangavel; Poojya Anantharam; Mohammad M Khan; Duraisamy Kempuraj; Asgar Zaheer
Journal:  Neurochem Res       Date:  2013-05-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.